RALLYBIO CORPORATION Basic Shares Outstanding (Weighted Average)
RALLYBIO CORPORATION (RLYB) reported Basic Shares Outstanding (Weighted Average) of 5.70 million shares for the 3-month period ending 2026-06-30, per its S-4/A filed 2026-08-26.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-26
- RALLYBIO CORPORATION weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 5.70M shares, a 1.68% increase year-over-year.
- RALLYBIO CORPORATION weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 5.69M shares, a 1.63% increase year-over-year.
- RALLYBIO CORPORATION weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was -112.16M shares.
- RALLYBIO CORPORATION weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 45.06M shares, a 1.04% increase year-over-year.
- RALLYBIO CORPORATION weighted average number of shares outstanding, basic for fiscal 2023 was 40.45M shares, a 27.11% increase from fiscal 2022.
- RALLYBIO CORPORATION weighted average number of shares outstanding, basic for fiscal 2022 was 31.82M shares, a 24.70% increase from fiscal 2021.
- RALLYBIO CORPORATION weighted average number of shares outstanding, basic for fiscal 2021 was 25.52M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 5.70M shares S-4/A · filed 2026-08-26 | 5.69M shares S-4/A · filed 2026-08-26 | -33.59M shares derived: average of 3 quarters · filed 2026-08-26 | -13.93M shares derived: average of 4 quarters · filed 2026-08-26 | |||
| 2026-03-31 | 5.69M shares S-4 · filed 2026-07-15 | -53.24M shares derived: average of 2 quarters · filed 2026-08-26 | -20.47M shares derived: average of 3 quarters · filed 2026-08-26 | -13.95M shares derived: average of 4 quarters · filed 2026-08-26 | |||
| 2025-12-31 | -112.16M shares derived: S-4/A 12 month − 10-Q 9 month · filed 2026-08-26 | -33.55M shares derived: average of 2 quarters · filed 2026-08-26 | -20.50M shares derived: average of 3 quarters · filed 2026-08-26 | 5.63M shares S-4/A · filed 2026-08-26 | |||
| 2025-09-30 | 45.06M shares 10-Q · filed 2025-11-06 | 25.33M shares derived: average of 2 quarters · filed 2026-08-26 | 44.89M shares 10-Q · filed 2025-11-06 | -12.87M shares derived: average of 4 quarters · filed 2026-08-26 | |||
| 2025-06-30 | 5.61M shares S-4/A · filed 2026-08-26 | 44.84M shares 10-Q · filed 2025-08-07 | 5.60M shares S-4/A · filed 2026-08-26 | 44.81M shares 10-Q · filed 2025-08-07 | -32.18M shares derived: average of 3 quarters · filed 2026-08-26 | -12.99M shares derived: average of 4 quarters · filed 2026-08-26 | |
| 2025-03-31 | 5.60M shares S-4 · filed 2026-07-15 | 44.77M shares 10-Q · filed 2025-05-08 | -51.07M shares derived: average of 2 quarters · filed 2026-08-26 | -19.18M shares derived: average of 3 quarters · filed 2026-08-26 | -3.35M shares derived: average of 4 quarters · filed 2026-08-26 | ||
| 2024-12-31 | -107.74M shares derived: S-4/A 12 month − 10-Q 9 month · filed 2026-08-26 | -31.57M shares derived: average of 2 quarters · filed 2026-08-26 | -6.34M shares derived: average of 3 quarters · filed 2026-08-26 | 5.44M shares S-4/A · filed 2026-08-26 | 43.54M shares 10-K · filed 2025-03-13 | ||
| 2024-09-30 | 44.59M shares 10-Q · filed 2025-11-06 | 44.36M shares derived: average of 2 quarters · filed 2025-11-06 | 43.17M shares 10-Q · filed 2025-11-06 | 42.53M shares derived: average of 4 quarters · filed 2025-11-06 | |||
| 2024-06-30 | 44.13M shares 10-Q · filed 2025-08-07 | 42.45M shares 10-Q · filed 2025-08-07 | 41.85M shares derived: average of 3 quarters · filed 2025-08-07 | 41.52M shares derived: average of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | 40.77M shares 10-Q · filed 2025-05-08 | 40.71M shares derived: average of 2 quarters · filed 2025-05-08 | 40.65M shares derived: average of 3 quarters · filed 2025-05-08 | 40.58M shares derived: average of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | 40.64M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | 40.59M shares derived: average of 2 quarters · filed 2025-03-13 | 40.51M shares derived: average of 3 quarters · filed 2025-03-13 | 40.45M shares 10-K · filed 2025-03-13 | |||
| 2023-09-30 | 40.53M shares 10-Q · filed 2024-11-07 | 40.45M shares derived: average of 2 quarters · filed 2024-11-07 | 40.38M shares 10-Q · filed 2024-11-07 | 39.19M shares derived: average of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | 40.36M shares 10-Q · filed 2024-08-08 | 40.31M shares 10-Q · filed 2024-08-08 | 38.74M shares derived: average of 3 quarters · filed 2024-08-08 | 36.75M shares derived: average of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | 40.25M shares 10-Q · filed 2024-05-09 | 37.92M shares derived: average of 2 quarters · filed 2024-05-09 | 35.54M shares derived: average of 3 quarters · filed 2024-05-09 | 34.30M shares derived: average of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | 35.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | 33.19M shares derived: average of 2 quarters · filed 2024-03-12 | 32.32M shares derived: average of 3 quarters · filed 2024-03-12 | 31.82M shares 10-K · filed 2024-03-12 | |||
| 2022-09-30 | 30.78M shares 10-Q · filed 2023-11-09 | 30.68M shares derived: average of 2 quarters · filed 2023-11-09 | 30.56M shares 10-Q · filed 2023-11-09 | 30.43M shares derived: average of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | 30.59M shares 10-Q · filed 2023-08-08 | 30.45M shares 10-Q · filed 2023-08-08 | 30.32M shares derived: average of 3 quarters · filed 2023-08-08 | 29.62M shares derived: average of 4 quarters · filed 2023-08-08 | |||
| 2022-03-31 | 30.32M shares 10-Q · filed 2023-05-09 | 30.18M shares derived: average of 2 quarters · filed 2023-05-09 | 29.30M shares derived: average of 3 quarters · filed 2023-05-09 | 27.61M shares derived: average of 4 quarters · filed 2023-05-09 | |||
| 2021-12-31 | 30.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | 28.78M shares derived: average of 2 quarters · filed 2023-03-06 | 26.71M shares derived: average of 3 quarters · filed 2023-03-06 | 25.52M shares 10-K · filed 2023-03-06 | |||
| 2021-09-30 | 27.53M shares 10-Q · filed 2022-11-07 | 25.04M shares derived: average of 2 quarters · filed 2022-11-07 | 24.01M shares 10-Q · filed 2022-11-07 | ||||
| 2021-06-30 | 22.56M shares 10-Q · filed 2022-08-08 | 22.31M shares 10-Q · filed 2022-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |